Mycoplasma pneumoniae, Culture
Mycoplasma pneumoniae is an important cause of pneumonia and contributes up to 20% of all community-acquired pneumonias across a wide range of age groups. Within certain susceptible groups such as school-going children, adolescents and young adults, it contributes up to 50% of the cases. Individuals acquire M. pneumoniae through aerosol inhalation. After an incubation period of 2-3 weeks, the individuals develop symptoms of upper respiratory tract infection and tracheobronchitis. About a third of the cases develop pneumonia. Extrapulmonary complications of M. pneumoniae are uncommon and include CNS manifestations such as meningoencephalitis, ascending paralysis, regional neuropathies and movement disorders. It may present as an autoimmune disorder presenting with pericarditis, arthritis, nephritis, mucocutaneous lesions and hemolytic anemia. In an otherwise healthy individual, the disease tends to be mild and requires supportive care and antibiotics in an ambulatory setting; however, in individuals with compromised immune status and/or other co-morbidities, the infections result in hospitalization, severe morbidity and death.
Laboratory diagnosis of M. pneumoniae is challenging and requires a combination of techniques to correctly identify the cases. Considerable levels of prevalence are noted among asymptomatic individuals, identified serologically and by nucleic acid amplification techniques. For this reason, interpretation of these tests requires clinical correlation. Polymerase chain reaction (PCR) yields faster results than culture and serology and has higher sensitivity and specificity than direct antigen detection and nucleic acid hybridization. Several PCR-based tests are commercially available including multiplex PCR, nested PCR and real-time PCR, all of which have reliable laboratory performance.
- Clinical diagnosis of Mycoplasma pneumoniae infection
- Treatment and disease management
Positive Mycoplasma pneumoniae culture indicates acute or current infection.
Negative
Conventional culture.
Respiratory specimen:
Collect the specimen (bronchial brushings, bronchoalveolar lavage fluid, tracheal aspirate, sputum, nasopharyngeal swabs) in a sterile container and contact the laboratory for transportation.
Extrapulmonary site:
Collect the fluid specimens (CSF, pleural and pericardial fluid) in a sterile container and contact the laboratory for transportation.
Stability
- Ambient - 24 hours
- Refrigerated - 5 days
- Frozen - 1 year
- Clin Microbiol Infect. 2003 Apr; 9(4):263-73. [PMID: 12667235]
- J Clin Microbiol. 1994 Jan; 32(1): 11–16. [PMID: 7510308]
- Curr Opin Infect Dis. 2001 Apr;14(2):181-6. [PMID: 11979130]
- Manual of Clinical Microbiology, 10th edition, pp. 970-985